This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $591,248 to St. Jude Children's Research Hospital Inc. to conduct research on SMARCAL1, a unique target in ALT-positive pediatric solid tumors. The award period runs from September 30, 2024 to September 29, 2026. St. Jude Children's Research Hospital Inc. is a nonprofit organization focused on pediatric cancer and other life-threatening diseases in children through research and clinical care. This grant enables St. Jude to perform innovative scientific studies to advance medical solutions for serious health conditions, contributing to the program's strategic approach of transforming health care for service members and the public through impactful biomedical research.
Generated 1/28/25, 11:09 AM